Loading...

Home
Stock
0BFRI

0BFRI News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

0BFRI News

BIOFRONTERA INC PLANS TO FILE SNDA WITH FDA IN Q3 2026

Feb 09 2026moomoo

BIOFRONTERA INC Reports 73.1% Lesion Clearance in FAS and 80.3% in PPS

Feb 09 2026moomoo

BIOFRONTERA INC - AMELUZ PDT SHOWS 45.6% CLEARANCE RATE IN PHASE 3 TRIAL

Feb 09 2026moomoo

BIOFRONTERA INC - PRIMARY ENDPOINT MET WITH FULL CLEARANCE RATE OF AK LESIONS

Feb 09 2026moomoo

BIOFRONTERA REPORTS SUCCESSFUL PHASE 3 STUDY RESULTS FOR AMELUZ® PDT TREATMENT OF ACTINIC KERATOSES ON EXTREMITIES, NECK, AND TRUNK, ACHIEVING PRIMARY ENDPOINT

Feb 09 2026moomoo

0BFRI Events

No data

No data

0BFRI Monitor News

No data

No data

0BFRI Earnings Analysis

No Data

No Data

People Also Watch